Season Finale: The FDA's Dr. Kathleen Donohue and RDCA- DAP
Jun 22, 2022 Ā·
28m 35s
Today on NORDpod, Andrew MacDowell stands in for Matthew Zachary, and he welcomes https://www.cuimc.columbia.edu/pulmonary/faculty-and-staff/kathleen-donohue-md, Director of the https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-rare-diseases-pediatrics-urologic-and-reproductive-medicine-division-rare-diseases-and. Over 350 million people worldwide have a rare disease, yet only 10%...
show more
Today on NORDpod, Andrew MacDowell stands in for Matthew Zachary, and he welcomes Dr. Kathleen Donohue, Director of the Division of Rare Diseases and Medical Genetics, at the FDAās Office of New Drugs. Over 350 million people worldwide have a rare disease, yet only 10% of rare diseases have an FDA-approved treatment. Dr. Donohue oversees the national hub designed to move the needle on that statistic, providing a shared pool of resources to spark new discoveries and speed up the creation of new therapies for rare diseases. Listen for the subtle sounds of the wild thunderstorm that rolls in during their taping as they talk through the critical role patient advocacy groups play in bringing rare disease patients into making these discoveries happen. Learn about the RDCA-DAP: the all-important central repository of shared data about rare diseases, with a very alphabet-soupy name. They also cover the powerful need for advocacy groups to ensure the data they collect from patients is gathered in a way that makes it possible for them to submit it to RDCA- DAP. NORDpod is the official podcast of the National Organization for Rare Disorders. For more information, email nordpod@rarediseases.org and visit https://rarediseases.org. RDCA-DAPĀ® is fully funded with a federal grant awarded to the Critical Path Institute: www.c-path.org/fda-acknowledgement. https://c-path.org/fda-acknowledgement.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
show less
Information
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
